Ex Vivo Transfer of the Hoxc-8-interacting Domain of Smad1 by a Tropism-modified Adenoviral Vector Results in Efficient Bone Formation in a Rabbit Model of Spinal Fusion

被引:7
作者
Douglas, Joanne T. [2 ,3 ,4 ,5 ,6 ]
Rivera, Angel A. [2 ,3 ,4 ]
Lyons, Gray R. [4 ]
Lott, Patricia F. [1 ]
Wang, Dezhi [1 ]
Zayzafoon, Majd [4 ,6 ]
Siegal, Gene P. [4 ,5 ,6 ]
Cao, Xu [4 ,6 ]
Theiss, Steven M. [1 ,6 ]
机构
[1] Univ Alabama, Div Orthoped Surg, Dept Surg, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL 35294 USA
[4] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[5] Univ Alabama, Gene Therapy Ctr, Birmingham, AL 35294 USA
[6] Univ Alabama, Ctr Metab Bone Dis, Birmingham, AL 35294 USA
来源
JOURNAL OF SPINAL DISORDERS & TECHNIQUES | 2010年 / 23卷 / 01期
关键词
adenoviral vector; bone marrow stromal cell; gene transfer; rabbit; spinal fusion; MESENCHYMAL STEM-CELLS; GENE-THERAPY; OSTEOBLAST DIFFERENTIATION; MORPHOGENETIC PROTEIN-7; MODIFIED FIBERS; BMP2; GENE; RECEPTOR; SPONDYLOLISTHESIS; OSTEOINDUCTION; EXPRESSION;
D O I
10.1097/BSD.0b013e318193b693
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design: Ex vivo gene transfer for spinal fusion. Objective: This study aimed to evaluate ex vivo transfer of the nuclear-localized Hoxc-8-interacting domain of Smad1 (termed Smad1C) to rabbit bone marrow stromal cells (BMSCs) by a tropism-modified human adenovirus serotype 5 (Ad5) vector as a novel therapeutic approach for spinal fusion. Summary of Background Data: Novel approaches are needed to improve the success of bone union after spinal fusion. One such approach is the ex vivo transfer of a gene encoding an osteoinductive factor to BMSCs which are subsequently reimplanted into the host. We have previously shown that heterologous expression of the Hoxc-8-interacting domain of Smad1 in the nuclei of osteoblast precursor cells is able to stimulate the expression of genes related to osteoblast differentiation and induce osteogenesis in vivo. Gene delivery vehicles based on human Ad5 are well suited for gene transfer for spinal fusion because they can mediate high-level, short-term gene expression. However, Ad5-based vectors with native tropism poorly transduce BMSCs, necessitating the use of vectors with modified tropism to achieve efficient gene transfer. Methods: The gene encoding Smad1C was transferred to rabbit BMSCs by an Ad5 vector with native tropism or a vector retargeted to alpha(v) integrins, which are abundantly expressed on rabbit BMSCs. Transduced BMSCs were maintained in osteoblastic differentiation medium for 30 days. Alkaline phosphatase activity was determined and cells stained for calcium deposition. As positive controls for osteogenesis, we used Ad5 vectors expressing bone morphogenetic protein 2. As negative controls, BMSCs were mock-transduced or transduced with an Ad5 vector expressing beta-galactosidase. In an immunocompetent rabbit model of spinal fusion, transduced BMSCs were coated onto absorbable gelatin sponge and implanted between decorticated transverse processes L6 and L7 of 8-week-old female New Zealand white rabbits. Animals were killed 4 weeks after implantation of the sponges, the fusion masses harvested and the area of new bone quantified using image analysis software. Results: The Smad1C-expressing tropism-modified Ad5 vector mediated a significantly higher level of alkaline phosphatase activity and calcium deposition in transduced rabbit BMSCs than all other vectors. The rabbit BMSCs transduced ex vivo with the Smad1C-expressing tropism-modified Ad5 vector mediated a greater amount of new bone formation than BMSCs transduced with any other vector. Conclusions: Delivery of the Smad1C gene construct to BMSCs by an alpha(v) integrin-targeted Ad5 vector shows promise for spinal fusion and other applications requiring the formation of new bone in vivo.
引用
收藏
页码:63 / 73
页数:11
相关论文
共 45 条
  • [1] Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy
    Alden, TD
    Pittman, DD
    Beres, EJ
    Hankins, GR
    Kallmes, DF
    Wisotsky, BM
    Kerns, KM
    Helm, GA
    [J]. JOURNAL OF NEUROSURGERY, 1999, 90 (01) : 109 - 114
  • [2] Targeted adenoviral vectors
    Barnett, BG
    Crews, CJ
    Douglas, JT
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2002, 1575 (1-3): : 1 - 14
  • [3] Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
    Bergelson, JM
    Cunningham, JA
    Droguett, G
    KurtJones, EA
    Krithivas, A
    Hong, JS
    Horwitz, MS
    Crowell, RL
    Finberg, RW
    [J]. SCIENCE, 1997, 275 (5304) : 1320 - 1323
  • [4] The use of rhBMP-2 in interbody fusion cages - Definitive evidence of osteoinduction in humans: A preliminary report
    Boden, SD
    Zdeblick, TA
    Sandhu, HS
    Heim, SE
    [J]. SPINE, 2000, 25 (03) : 376 - 381
  • [5] THE ROLE OF FUSION AND INSTRUMENTATION IN THE TREATMENT OF DEGENERATIVE SPONDYLOLISTHESIS WITH SPINAL STENOSIS
    BRIDWELL, KH
    SEDGEWICK, TA
    OBRIEN, MF
    LENKE, LG
    BALDUS, C
    [J]. JOURNAL OF SPINAL DISORDERS, 1993, 6 (06): : 461 - 472
  • [6] Clark G., 1981, Staining Procedures, P187
  • [7] Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO
  • [8] 2-C
  • [9] An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
    Dmitriev, I
    Krasnykh, V
    Miller, CR
    Wang, MH
    Kashentseva, E
    Mikheeva, G
    Belousova, N
    Curiel, DT
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (12) : 9706 - 9713
  • [10] Adenoviral vectors for gene therapy
    Douglas, Joanne T.
    [J]. MOLECULAR BIOTECHNOLOGY, 2007, 36 (01) : 71 - 80